Skip to content

STEDIPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

STEDIPHAR

BE 0477.059.361
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€207,443
2024 · €226,168-€18,725
Equity
€325,335
2024 · €297,892+€27,443
Cash
€53,865
2024 · €708,064-€654,199
Balance sheet total
€1.1m
2024 · €1.3m-€216,692

Largest movements

2024 to 2025
Assets
  • Cash -€654,199

    down €654,199 (-92.4%), from €708,064 to €53,865

    mainly Current investments (-€300,000) and Other debts (-€225,422)

  • Current investments +€300,000

    new in 2025: €300,000

  • Receivables within one year +€141,343

    up €141,343 (+44.4%), from €317,989 to €459,333

    of which Other amounts receivable: +€235,300

Equity and liabilities
  • Other debts -€225,422

    down €225,422 (-37.0%), from €608,737 to €383,316

  • Reserves +€27,443

    up €27,443 (+10.2%), from €269,500 to €296,943

  • Tax, wage and social debts -€19,341

    down €19,341 (-46.3%), from €41,770 to €22,429

    of which Taxes: -€17,156

Income statement
  • Gross operating margin +€41,144

    up €41,144 (+11.8%), from €350,070 to €391,214

  • Staff costs +€34,288

    up €34,288 (+30.8%), from €111,465 to €145,753

  • Financial income -€22,281

    down €22,281 (-58.2%), from €38,265 to €15,984

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €226,168
Gross operating margin +€41,144
Staff costs -€34,288
Depreciation -€2,321
Other operating charges -€600
Financial income -€22,281
Financial charges -€839
Taxes +€460
Result 2025 €207,443
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€165,451
Investment -€318,853
Financing -€169,895
Cash 2024 €708,064
Net result for the year +€207,443
Depreciation +€10,987
Stocks and contracts +€6,108
Receivables within one year -€141,343
Deferred charges and accrued income +€5,595
Trade debts -€9,479
Tax, wage and social debts -€19,341
Other debts -€225,422
Accrued charges and deferred income +€1
Investment in fixed assets (net) -€18,853
Current investments -€300,000
Current portion of long-term debt +€10,105
Contributions, distributions and other -€180,000
Cash 2025 €53,865
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,302,501 €1,085,810 -€216,692 -16.6%
Fixed assets 21/28 €58,092 €65,959 +€7,867 +13.5%
Intangible fixed assets 21 - €3,163 +€3,163
Tangible fixed assets 22/27 €57,453 €62,057 +€4,603 +8.0%
Land and buildings 22 €35,082 €33,970 -€1,112 -3.2%
Plant, machinery and equipment 23 €13,668 €22,164 +€8,497 +62.2%
Furniture and vehicles 24 €8,703 €5,923 -€2,781 -31.9%
Financial fixed assets 28 €639 €739 +€100 +15.6%
Current assets 29/58 €1,244,409 €1,019,851 -€224,559 -18.0%
Stocks and contracts in progress 3 €190,649 €184,541 -€6,108 -3.2%
Stocks 30/36 €190,649 €184,541 -€6,108 -3.2%
Amounts receivable within one year 40/41 €317,989 €459,333 +€141,343 +44.4%
Trade receivables 40 €279,420 €185,463 -€93,957 -33.6%
Other amounts receivable 41 €38,569 €273,870 +€235,300 +610%
Current investments 50/53 - €300,000 +€300,000
Cash at bank and in hand 54/58 €708,064 €53,865 -€654,199 -92.4%
Deferred charges and accrued income 490/1 €27,707 €22,112 -€5,595 -20.2%
Total equity and liabilities 10/49 €1,302,501 €1,085,810 -€216,692 -16.6%
Equity 10/15 €297,892 €325,335 +€27,443 +9.2%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €269,500 €296,943 +€27,443 +10.2%
Distributable reserves 133 €269,500 €296,943 +€27,443 +10.2%
Profit (loss) carried forward 14 €9,792 €9,792 = 0.0%
Amounts payable 17/49 €1,004,610 €760,475 -€244,135 -24.3%
Amounts payable within one year 42/48 €1,004,456 €760,320 -€244,136 -24.3%
Current portion of amounts payable after more than one year 42 - €10,105 +€10,105
Trade debts 44 €353,948 €344,469 -€9,479 -2.7%
Suppliers 440/4 €353,948 €344,469 -€9,479 -2.7%
Taxes, remuneration and social security 45 €41,770 €22,429 -€19,341 -46.3%
Taxes 450/3 €21,677 €4,521 -€17,156 -79.1%
Remuneration and social security 454/9 €20,093 €17,908 -€2,185 -10.9%
Other amounts payable 47/48 €608,737 €383,316 -€225,422 -37.0%
Accrued charges and deferred income 492/3 €154 €155 +€1 +0.9%
Remuneration, social security and pensions 62 €111,465 €145,753 +€34,288 +30.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,665 €10,987 +€2,321 +26.8%
Other operating charges 640/8 €4,391 €4,991 +€600 +13.7%
Gross operating margin 9900 €350,070 €391,214 +€41,144 +11.8%
Operating profit (loss) 9901 €225,549 €229,484 +€3,934 +1.7%
Financial income 75/76B €38,265 €15,984 -€22,281 -58.2%
Recurring financial income 75 €38,265 €15,984 -€22,281 -58.2%
Financial charges 65/66B €19,269 €20,108 +€839 +4.4%
Recurring financial charges 65 €19,269 €20,108 +€839 +4.4%
Profit (loss) for the period before taxes 9903 €244,546 €225,360 -€19,185 -7.8%
Income taxes 67/77 €18,377 €17,917 -€460 -2.5%
Profit (loss) for the period 9904 €226,168 €207,443 -€18,725 -8.3%
Profit (loss) for the period to be appropriated 9905 €226,168 €207,443 -€18,725 -8.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.